Index by author
March 01, 2009; Volume 37,Issue 3
A
Abe, Koji
- You have accessUse of Sandwich-Cultured Human Hepatocytes to Predict Biliary Clearance of Angiotensin II Receptor Blockers and HMG-CoA Reductase InhibitorsKoji Abe, Arlene S. Bridges and Kim L. R. BrouwerDrug Metabolism and Disposition March 2009, 37 (3) 447-452; DOI: https://doi.org/10.1124/dmd.108.023465
Agarwal, Sagar
- You have accessSubstrate-Dependent Breast Cancer Resistance Protein (Bcrp1/Abcg2)-Mediated Interactions: Consideration of Multiple Binding Sites in in Vitro Assay DesignNagdeep Giri, Sagar Agarwal, Naveed Shaik, Guoyu Pan, Ying Chen and William F. ElmquistDrug Metabolism and Disposition March 2009, 37 (3) 560-570; DOI: https://doi.org/10.1124/dmd.108.022046
Allen, Darin
- You have accessMetabolism of (+)-1,4-Dihydro-7-(trans-3-methoxy-4-methylamino-1-pyrrolidinyl)-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic Acid (Voreloxin; Formerly SNS-595), a Novel Replication-Dependent DNA-Damaging AgentMarc J. Evanchik, Darin Allen, Josh C. Yoburn, Jeffrey A. Silverman and Ute HochDrug Metabolism and Disposition March 2009, 37 (3) 594-601; DOI: https://doi.org/10.1124/dmd.108.023432
Anderson, Alan
- You have accessDexamethasone Induction of Murine CYP2B Genes Requires the Glucocorticoid ReceptorÉtienne Audet-Walsh and Alan AndersonDrug Metabolism and Disposition March 2009, 37 (3) 580-588; DOI: https://doi.org/10.1124/dmd.108.022772
Audet-Walsh, Étienne
- You have accessDexamethasone Induction of Murine CYP2B Genes Requires the Glucocorticoid ReceptorÉtienne Audet-Walsh and Alan AndersonDrug Metabolism and Disposition March 2009, 37 (3) 580-588; DOI: https://doi.org/10.1124/dmd.108.022772
B
Bandiera, Stelvio M.
- You have accessDevelopmental Expression and Endocrine Regulation of CYP1B1 in Rat TestisGrace S. Leung, Masahiko Kawai, Jenny K. Tai, Jie Chen, Stelvio M. Bandiera and Thomas K. H. ChangDrug Metabolism and Disposition March 2009, 37 (3) 523-528; DOI: https://doi.org/10.1124/dmd.108.025635
Batard, Yannick
- You have accessAbsorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in HumansHandan He, Phi Tran, Hequn Yin, Harold Smith, Yannick Batard, Lai Wang, Heidi Einolf, Helen Gu, James B. Mangold, Volker Fischer and Dan HowardDrug Metabolism and Disposition March 2009, 37 (3) 536-544; DOI: https://doi.org/10.1124/dmd.108.023010
Bednarski, Patrick J.
- You have accessInvestigation of the in Vitro Metabolism of the Analgesic FlupirtineKaren Methling, Przyemslaw Reszka, Michael Lalk, Oldrich Vrana, Eberhard Scheuch, Werner Siegmund, Bernd Terhaag and Patrick J. BednarskiDrug Metabolism and Disposition March 2009, 37 (3) 479-493; DOI: https://doi.org/10.1124/dmd.108.024364
Berg, Jeannette Zinggeler
- You have accessEffect of CYP2A13 Active Site Mutation N297A on Metabolism of Coumarin and Tobacco-Specific NitrosaminesKari E. Schlicht, Jeannette Zinggeler Berg and Sharon E. MurphyDrug Metabolism and Disposition March 2009, 37 (3) 665-671; DOI: https://doi.org/10.1124/dmd.108.025072
Berry, Karen
- You have accessAn Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple DosingGeorge R. Tonn, Simon G. Wong, Sylvia C. Wong, Michael G. Johnson, Ji Ma, Robert Cho, Leslie C. Floren, Kathryn Kersey, Karen Berry, Andrew P. Marcus, Xuemei Wang, Bettina Van Lengerich, Julio C. Medina, Paul G. Pearson and Bradley K. WongDrug Metabolism and Disposition March 2009, 37 (3) 502-513; DOI: https://doi.org/10.1124/dmd.108.021931
Bridges, Arlene S.
- You have accessUse of Sandwich-Cultured Human Hepatocytes to Predict Biliary Clearance of Angiotensin II Receptor Blockers and HMG-CoA Reductase InhibitorsKoji Abe, Arlene S. Bridges and Kim L. R. BrouwerDrug Metabolism and Disposition March 2009, 37 (3) 447-452; DOI: https://doi.org/10.1124/dmd.108.023465
- You have accessFexofenadine Brain Exposure and the Influence of Blood-Brain Barrier P-Glycoprotein After Fexofenadine and Terfenadine AdministrationRong Zhao, J. Cory Kalvass, Souzan B. Yanni, Arlene S. Bridges and Gary M. PollackDrug Metabolism and Disposition March 2009, 37 (3) 529-535; DOI: https://doi.org/10.1124/dmd.107.019893
Brouwer, Kim L. R.
- You have accessUse of Sandwich-Cultured Human Hepatocytes to Predict Biliary Clearance of Angiotensin II Receptor Blockers and HMG-CoA Reductase InhibitorsKoji Abe, Arlene S. Bridges and Kim L. R. BrouwerDrug Metabolism and Disposition March 2009, 37 (3) 447-452; DOI: https://doi.org/10.1124/dmd.108.023465
C
Carrizosa, Daniel R.
- You have accessIdentification of a Cranberry Juice Product that Inhibits Enteric CYP3A-Mediated First-Pass Metabolism in HumansNgoc Ngo, Zhixia Yan, Tyler N. Graf, Daniel R. Carrizosa, Angela D. M. Kashuba, E. Claire Dees, Nicholas H. Oberlies and Mary F. PaineDrug Metabolism and Disposition March 2009, 37 (3) 514-522; DOI: https://doi.org/10.1124/dmd.108.024968
Cashman, John R.
- You have accessHepatic Flavin-Containing Monooxygenase Gene Regulation in Different Mouse Inflammation ModelsJun Zhang, Madhusudana R. Chaluvadi, Rob Reddy, Meike S. Motika, Terrilyn A. Richardson, John R. Cashman and Edward T. MorganDrug Metabolism and Disposition March 2009, 37 (3) 462-468; DOI: https://doi.org/10.1124/dmd.108.025338
Chaluvadi, Madhusudana R.
- You have accessHepatic Flavin-Containing Monooxygenase Gene Regulation in Different Mouse Inflammation ModelsJun Zhang, Madhusudana R. Chaluvadi, Rob Reddy, Meike S. Motika, Terrilyn A. Richardson, John R. Cashman and Edward T. MorganDrug Metabolism and Disposition March 2009, 37 (3) 462-468; DOI: https://doi.org/10.1124/dmd.108.025338
Chang, Thomas K. H.
- You have accessDevelopmental Expression and Endocrine Regulation of CYP1B1 in Rat TestisGrace S. Leung, Masahiko Kawai, Jenny K. Tai, Jie Chen, Stelvio M. Bandiera and Thomas K. H. ChangDrug Metabolism and Disposition March 2009, 37 (3) 523-528; DOI: https://doi.org/10.1124/dmd.108.025635
Chen, Jie
- You have accessDevelopmental Expression and Endocrine Regulation of CYP1B1 in Rat TestisGrace S. Leung, Masahiko Kawai, Jenny K. Tai, Jie Chen, Stelvio M. Bandiera and Thomas K. H. ChangDrug Metabolism and Disposition March 2009, 37 (3) 523-528; DOI: https://doi.org/10.1124/dmd.108.025635
Chen, Ying
- You have accessSubstrate-Dependent Breast Cancer Resistance Protein (Bcrp1/Abcg2)-Mediated Interactions: Consideration of Multiple Binding Sites in in Vitro Assay DesignNagdeep Giri, Sagar Agarwal, Naveed Shaik, Guoyu Pan, Ying Chen and William F. ElmquistDrug Metabolism and Disposition March 2009, 37 (3) 560-570; DOI: https://doi.org/10.1124/dmd.108.022046
Chiang, John Y. L.
- You have accessMechanism of Vitamin D Receptor Inhibition of Cholesterol 7α-Hydroxylase Gene Transcription in Human HepatocytesShuxin Han and John Y. L. ChiangDrug Metabolism and Disposition March 2009, 37 (3) 469-478; DOI: https://doi.org/10.1124/dmd.108.025155
Cho, Robert
- You have accessAn Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple DosingGeorge R. Tonn, Simon G. Wong, Sylvia C. Wong, Michael G. Johnson, Ji Ma, Robert Cho, Leslie C. Floren, Kathryn Kersey, Karen Berry, Andrew P. Marcus, Xuemei Wang, Bettina Van Lengerich, Julio C. Medina, Paul G. Pearson and Bradley K. WongDrug Metabolism and Disposition March 2009, 37 (3) 502-513; DOI: https://doi.org/10.1124/dmd.108.021931
D
Dansette, Patrick M.
- You have accessDehydrogenation of the Indoline-Containing Drug 4-Chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide (Indapamide) by CYP3A4: Correlation with in Silico PredictionsHao Sun, Chad Moore, Patrick M. Dansette, Santosh Kumar, James R. Halpert and Garold S. YostDrug Metabolism and Disposition March 2009, 37 (3) 672-684; DOI: https://doi.org/10.1124/dmd.108.022707
Dees, E. Claire
- You have accessIdentification of a Cranberry Juice Product that Inhibits Enteric CYP3A-Mediated First-Pass Metabolism in HumansNgoc Ngo, Zhixia Yan, Tyler N. Graf, Daniel R. Carrizosa, Angela D. M. Kashuba, E. Claire Dees, Nicholas H. Oberlies and Mary F. PaineDrug Metabolism and Disposition March 2009, 37 (3) 514-522; DOI: https://doi.org/10.1124/dmd.108.024968
Ding, Xinxin
- You have accessAn Intestinal Epithelium-Specific Cytochrome P450 (P450) Reductase-Knockout Mouse Model: Direct Evidence for a Role of Intestinal P450s in First-Pass Clearance of Oral NifedipineQing-Yu Zhang, Cheng Fang, Jin Zhang, Deborah Dunbar, Laurence Kaminsky and Xinxin DingDrug Metabolism and Disposition March 2009, 37 (3) 651-657; DOI: https://doi.org/10.1124/dmd.108.025429
Dunbar, Deborah
- You have accessAn Intestinal Epithelium-Specific Cytochrome P450 (P450) Reductase-Knockout Mouse Model: Direct Evidence for a Role of Intestinal P450s in First-Pass Clearance of Oral NifedipineQing-Yu Zhang, Cheng Fang, Jin Zhang, Deborah Dunbar, Laurence Kaminsky and Xinxin DingDrug Metabolism and Disposition March 2009, 37 (3) 651-657; DOI: https://doi.org/10.1124/dmd.108.025429
E
Einolf, Heidi
- You have accessAbsorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in HumansHandan He, Phi Tran, Hequn Yin, Harold Smith, Yannick Batard, Lai Wang, Heidi Einolf, Helen Gu, James B. Mangold, Volker Fischer and Dan HowardDrug Metabolism and Disposition March 2009, 37 (3) 536-544; DOI: https://doi.org/10.1124/dmd.108.023010
Elmquist, William F.
- You have accessSubstrate-Dependent Breast Cancer Resistance Protein (Bcrp1/Abcg2)-Mediated Interactions: Consideration of Multiple Binding Sites in in Vitro Assay DesignNagdeep Giri, Sagar Agarwal, Naveed Shaik, Guoyu Pan, Ying Chen and William F. ElmquistDrug Metabolism and Disposition March 2009, 37 (3) 560-570; DOI: https://doi.org/10.1124/dmd.108.022046
Ethell, Brian T.
- You have accessEvaluation of Escherichia coli Membrane Preparations of Canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with Coexpressed Canine Cytochrome P450 ReductaseCharles W. Locuson, Brian T. Ethell, Michael Voice, David Lee and Kenneth L. FeenstraDrug Metabolism and Disposition March 2009, 37 (3) 457-461; DOI: https://doi.org/10.1124/dmd.108.025312
Evanchik, Marc J.
- You have accessMetabolism of (+)-1,4-Dihydro-7-(trans-3-methoxy-4-methylamino-1-pyrrolidinyl)-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic Acid (Voreloxin; Formerly SNS-595), a Novel Replication-Dependent DNA-Damaging AgentMarc J. Evanchik, Darin Allen, Josh C. Yoburn, Jeffrey A. Silverman and Ute HochDrug Metabolism and Disposition March 2009, 37 (3) 594-601; DOI: https://doi.org/10.1124/dmd.108.023432
F
Fang, Cheng
- You have accessAn Intestinal Epithelium-Specific Cytochrome P450 (P450) Reductase-Knockout Mouse Model: Direct Evidence for a Role of Intestinal P450s in First-Pass Clearance of Oral NifedipineQing-Yu Zhang, Cheng Fang, Jin Zhang, Deborah Dunbar, Laurence Kaminsky and Xinxin DingDrug Metabolism and Disposition March 2009, 37 (3) 651-657; DOI: https://doi.org/10.1124/dmd.108.025429
Fardel, Olivier
- You have accessRegulation of Drug Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokines Tumor Necrosis Factor-α or Interleukin-6Marc Le Vee, Valérie Lecureur, Bruno Stieger and Olivier FardelDrug Metabolism and Disposition March 2009, 37 (3) 685-693; DOI: https://doi.org/10.1124/dmd.108.023630
Farhadi, Ashkan
- You have accessSIMDOT-AbMe: Microphysiologically Based Simulation Tool for Quantitative Prediction of Systemic and Local Bioavailability of Targeted Oral Delivery FormulationsNahor Haddish-Berhane, Ashkan Farhadi, Chell Nyquist, Kamyar Haghighi and Ali KeshavarzianDrug Metabolism and Disposition March 2009, 37 (3) 608-618; DOI: https://doi.org/10.1124/dmd.108.021949
Farid, Nagy A.
- You have accessMechanism-Based Inhibition of Human Cytochrome P450 2B6 by Ticlopidine, Clopidogrel, and the Thiolactone Metabolite of PrasugrelYumi Nishiya, Katsunobu Hagihara, Takashi Ito, Masami Tajima, Shin-ichi Miura, Atsushi Kurihara, Nagy A. Farid and Toshihiko IkedaDrug Metabolism and Disposition March 2009, 37 (3) 589-593; DOI: https://doi.org/10.1124/dmd.108.022988
Fawcett, J. Paul
- You have accessMechanism of CYP2C9 Inhibition by Flavones and FlavonolsDayong Si, Ying Wang, Yi-Han Zhou, Yingjie Guo, Juan Wang, Hui Zhou, Ze-Sheng Li and J. Paul FawcettDrug Metabolism and Disposition March 2009, 37 (3) 629-634; DOI: https://doi.org/10.1124/dmd.108.023416
Feenstra, Kenneth L.
- You have accessEvaluation of Escherichia coli Membrane Preparations of Canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with Coexpressed Canine Cytochrome P450 ReductaseCharles W. Locuson, Brian T. Ethell, Michael Voice, David Lee and Kenneth L. FeenstraDrug Metabolism and Disposition March 2009, 37 (3) 457-461; DOI: https://doi.org/10.1124/dmd.108.025312
Filipeck, Ron
- You have accessDisposition of Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Rats and DogsHandan He, Phi Tran, Hequn Yin, Harold Smith, Dennis Flood, Roger Kramp, Ron Filipeck, Volker Fischer and Dan HowardDrug Metabolism and Disposition March 2009, 37 (3) 545-554; DOI: https://doi.org/10.1124/dmd.108.023002
Fischer, Volker
- You have accessAbsorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in HumansHandan He, Phi Tran, Hequn Yin, Harold Smith, Yannick Batard, Lai Wang, Heidi Einolf, Helen Gu, James B. Mangold, Volker Fischer and Dan HowardDrug Metabolism and Disposition March 2009, 37 (3) 536-544; DOI: https://doi.org/10.1124/dmd.108.023010
- You have accessDisposition of Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Rats and DogsHandan He, Phi Tran, Hequn Yin, Harold Smith, Dennis Flood, Roger Kramp, Ron Filipeck, Volker Fischer and Dan HowardDrug Metabolism and Disposition March 2009, 37 (3) 545-554; DOI: https://doi.org/10.1124/dmd.108.023002
Flood, Dennis
- You have accessDisposition of Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Rats and DogsHandan He, Phi Tran, Hequn Yin, Harold Smith, Dennis Flood, Roger Kramp, Ron Filipeck, Volker Fischer and Dan HowardDrug Metabolism and Disposition March 2009, 37 (3) 545-554; DOI: https://doi.org/10.1124/dmd.108.023002
Floren, Leslie C.
- You have accessAn Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple DosingGeorge R. Tonn, Simon G. Wong, Sylvia C. Wong, Michael G. Johnson, Ji Ma, Robert Cho, Leslie C. Floren, Kathryn Kersey, Karen Berry, Andrew P. Marcus, Xuemei Wang, Bettina Van Lengerich, Julio C. Medina, Paul G. Pearson and Bradley K. WongDrug Metabolism and Disposition March 2009, 37 (3) 502-513; DOI: https://doi.org/10.1124/dmd.108.021931
G
Giri, Nagdeep
- You have accessSubstrate-Dependent Breast Cancer Resistance Protein (Bcrp1/Abcg2)-Mediated Interactions: Consideration of Multiple Binding Sites in in Vitro Assay DesignNagdeep Giri, Sagar Agarwal, Naveed Shaik, Guoyu Pan, Ying Chen and William F. ElmquistDrug Metabolism and Disposition March 2009, 37 (3) 560-570; DOI: https://doi.org/10.1124/dmd.108.022046
Graf, Tyler N.
- You have accessIdentification of a Cranberry Juice Product that Inhibits Enteric CYP3A-Mediated First-Pass Metabolism in HumansNgoc Ngo, Zhixia Yan, Tyler N. Graf, Daniel R. Carrizosa, Angela D. M. Kashuba, E. Claire Dees, Nicholas H. Oberlies and Mary F. PaineDrug Metabolism and Disposition March 2009, 37 (3) 514-522; DOI: https://doi.org/10.1124/dmd.108.024968
Grönberg, Gunnar
- You have accessNovel Metabolites of Amodiaquine Formed by CYP1A1 and CYP1B1: Structure Elucidation Using Electrochemistry, Mass Spectrometry, and NMRTove Johansson, Ulrik Jurva, Gunnar Grönberg, Lars Weidolf and Collen MasimirembwaDrug Metabolism and Disposition March 2009, 37 (3) 571-579; DOI: https://doi.org/10.1124/dmd.108.025171
Gu, Helen
- You have accessAbsorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in HumansHandan He, Phi Tran, Hequn Yin, Harold Smith, Yannick Batard, Lai Wang, Heidi Einolf, Helen Gu, James B. Mangold, Volker Fischer and Dan HowardDrug Metabolism and Disposition March 2009, 37 (3) 536-544; DOI: https://doi.org/10.1124/dmd.108.023010
Guo, Yingjie
- You have accessMechanism of CYP2C9 Inhibition by Flavones and FlavonolsDayong Si, Ying Wang, Yi-Han Zhou, Yingjie Guo, Juan Wang, Hui Zhou, Ze-Sheng Li and J. Paul FawcettDrug Metabolism and Disposition March 2009, 37 (3) 629-634; DOI: https://doi.org/10.1124/dmd.108.023416
H
Haddish-Berhane, Nahor
- You have accessSIMDOT-AbMe: Microphysiologically Based Simulation Tool for Quantitative Prediction of Systemic and Local Bioavailability of Targeted Oral Delivery FormulationsNahor Haddish-Berhane, Ashkan Farhadi, Chell Nyquist, Kamyar Haghighi and Ali KeshavarzianDrug Metabolism and Disposition March 2009, 37 (3) 608-618; DOI: https://doi.org/10.1124/dmd.108.021949
Haghighi, Kamyar
- You have accessSIMDOT-AbMe: Microphysiologically Based Simulation Tool for Quantitative Prediction of Systemic and Local Bioavailability of Targeted Oral Delivery FormulationsNahor Haddish-Berhane, Ashkan Farhadi, Chell Nyquist, Kamyar Haghighi and Ali KeshavarzianDrug Metabolism and Disposition March 2009, 37 (3) 608-618; DOI: https://doi.org/10.1124/dmd.108.021949
Hagihara, Katsunobu
- You have accessMechanism-Based Inhibition of Human Cytochrome P450 2B6 by Ticlopidine, Clopidogrel, and the Thiolactone Metabolite of PrasugrelYumi Nishiya, Katsunobu Hagihara, Takashi Ito, Masami Tajima, Shin-ichi Miura, Atsushi Kurihara, Nagy A. Farid and Toshihiko IkedaDrug Metabolism and Disposition March 2009, 37 (3) 589-593; DOI: https://doi.org/10.1124/dmd.108.022988
Halpert, James R.
- You have accessDecreased Susceptibility of the Cytochrome P450 2B6 Variant K262R to Inhibition by Several Clinically Important DrugsJyothi C. Talakad, Santosh Kumar and James R. HalpertDrug Metabolism and Disposition March 2009, 37 (3) 644-650; DOI: https://doi.org/10.1124/dmd.108.023655
- You have accessDehydrogenation of the Indoline-Containing Drug 4-Chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide (Indapamide) by CYP3A4: Correlation with in Silico PredictionsHao Sun, Chad Moore, Patrick M. Dansette, Santosh Kumar, James R. Halpert and Garold S. YostDrug Metabolism and Disposition March 2009, 37 (3) 672-684; DOI: https://doi.org/10.1124/dmd.108.022707
Hammarlund-Udenaes, Margareta
- You have accessSpecies Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein TransportStina Syvänen, Örjan Lindhe, Mikael Palner, Birgitte R. Kornum, Obaidur Rahman, Bengt Långström, Gitte M. Knudsen and Margareta Hammarlund-UdenaesDrug Metabolism and Disposition March 2009, 37 (3) 635-643; DOI: https://doi.org/10.1124/dmd.108.024745
Han, Shuxin
- You have accessMechanism of Vitamin D Receptor Inhibition of Cholesterol 7α-Hydroxylase Gene Transcription in Human HepatocytesShuxin Han and John Y. L. ChiangDrug Metabolism and Disposition March 2009, 37 (3) 469-478; DOI: https://doi.org/10.1124/dmd.108.025155
Harada, Akihiro
- You have accessInvestigation of the Role of Oligopeptide Transporter PEPT1 and Sodium/Glucose Cotransporter SGLT1 in Intestinal Absorption of Their Substrates Using Small GTP-Binding Protein Rab8-Null MiceYukio Kato, Tomoko Sugiura, Yasuhito Nakadera, Mikihiro Sugiura, Yoshiyuki Kubo, Takashi Sato, Akihiro Harada and Akira TsujiDrug Metabolism and Disposition March 2009, 37 (3) 602-607; DOI: https://doi.org/10.1124/dmd.108.023689
He, Handan
- You have accessAbsorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in HumansHandan He, Phi Tran, Hequn Yin, Harold Smith, Yannick Batard, Lai Wang, Heidi Einolf, Helen Gu, James B. Mangold, Volker Fischer and Dan HowardDrug Metabolism and Disposition March 2009, 37 (3) 536-544; DOI: https://doi.org/10.1124/dmd.108.023010
- You have accessDisposition of Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Rats and DogsHandan He, Phi Tran, Hequn Yin, Harold Smith, Dennis Flood, Roger Kramp, Ron Filipeck, Volker Fischer and Dan HowardDrug Metabolism and Disposition March 2009, 37 (3) 545-554; DOI: https://doi.org/10.1124/dmd.108.023002
Hoch, Ute
- You have accessMetabolism of (+)-1,4-Dihydro-7-(trans-3-methoxy-4-methylamino-1-pyrrolidinyl)-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic Acid (Voreloxin; Formerly SNS-595), a Novel Replication-Dependent DNA-Damaging AgentMarc J. Evanchik, Darin Allen, Josh C. Yoburn, Jeffrey A. Silverman and Ute HochDrug Metabolism and Disposition March 2009, 37 (3) 594-601; DOI: https://doi.org/10.1124/dmd.108.023432
Horita, Shigeru
- You have accessThe Inhibition of Human Multidrug and Toxin Extrusion 1 Is Involved in the Drug-Drug Interaction Caused by CimetidineSoichiro Matsushima, Kazuya Maeda, Katsuhisa Inoue, Kin-ya Ohta, Hiroaki Yuasa, Tsunenori Kondo, Hideki Nakayama, Shigeru Horita, Hiroyuki Kusuhara and Yuichi SugiyamaDrug Metabolism and Disposition March 2009, 37 (3) 555-559; DOI: https://doi.org/10.1124/dmd.108.023911
Howard, Dan
- You have accessAbsorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in HumansHandan He, Phi Tran, Hequn Yin, Harold Smith, Yannick Batard, Lai Wang, Heidi Einolf, Helen Gu, James B. Mangold, Volker Fischer and Dan HowardDrug Metabolism and Disposition March 2009, 37 (3) 536-544; DOI: https://doi.org/10.1124/dmd.108.023010
- You have accessDisposition of Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Rats and DogsHandan He, Phi Tran, Hequn Yin, Harold Smith, Dennis Flood, Roger Kramp, Ron Filipeck, Volker Fischer and Dan HowardDrug Metabolism and Disposition March 2009, 37 (3) 545-554; DOI: https://doi.org/10.1124/dmd.108.023002
I
Ikeda, Toshihiko
- You have accessMechanism-Based Inhibition of Human Cytochrome P450 2B6 by Ticlopidine, Clopidogrel, and the Thiolactone Metabolite of PrasugrelYumi Nishiya, Katsunobu Hagihara, Takashi Ito, Masami Tajima, Shin-ichi Miura, Atsushi Kurihara, Nagy A. Farid and Toshihiko IkedaDrug Metabolism and Disposition March 2009, 37 (3) 589-593; DOI: https://doi.org/10.1124/dmd.108.022988
Inoue, Katsuhisa
- You have accessThe Inhibition of Human Multidrug and Toxin Extrusion 1 Is Involved in the Drug-Drug Interaction Caused by CimetidineSoichiro Matsushima, Kazuya Maeda, Katsuhisa Inoue, Kin-ya Ohta, Hiroaki Yuasa, Tsunenori Kondo, Hideki Nakayama, Shigeru Horita, Hiroyuki Kusuhara and Yuichi SugiyamaDrug Metabolism and Disposition March 2009, 37 (3) 555-559; DOI: https://doi.org/10.1124/dmd.108.023911
Ito, Takashi
- You have accessMechanism-Based Inhibition of Human Cytochrome P450 2B6 by Ticlopidine, Clopidogrel, and the Thiolactone Metabolite of PrasugrelYumi Nishiya, Katsunobu Hagihara, Takashi Ito, Masami Tajima, Shin-ichi Miura, Atsushi Kurihara, Nagy A. Farid and Toshihiko IkedaDrug Metabolism and Disposition March 2009, 37 (3) 589-593; DOI: https://doi.org/10.1124/dmd.108.022988
Iwai, Megumi
- You have accessCarrier-Mediated Uptake of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium Bromide (YM155 Monobromide), a Novel Small-Molecule Survivin Suppressant, into Human Solid Tumor and Lymphoma CellsTsuyoshi Minematsu, Megumi Iwai, Kenji Sugimoto, Nobuaki Shirai, Takahito Nakahara, Takashi Usui and Hidetaka KamimuraDrug Metabolism and Disposition March 2009, 37 (3) 619-628; DOI: https://doi.org/10.1124/dmd.108.025254
J
Jasko, Maxim V.
- You have access5′-Aminocarbonyl Phosphonates as New Zidovudine Depot Forms: Antiviral Properties, Intracellular Transformations, and Pharmacokinetic ParametersAnastasia L. Khandazhinskaya, Dmitry V. Yanvarev, Maxim V. Jasko, Alexander V. Shipitsin, Vsevolod A. Khalizev, Stanislav I. Shram, Yuriy S. Skoblov, Elena A. Shirokova and Marina K. KukhanovaDrug Metabolism and Disposition March 2009, 37 (3) 494-501; DOI: https://doi.org/10.1124/dmd.108.022269
Jiang, Xi-Ling
- You have accessPinoline May be Used as a Probe for CYP2D6 ActivityXi-Ling Jiang, Hong-Wu Shen and Ai-Ming YuDrug Metabolism and Disposition March 2009, 37 (3) 443-446; DOI: https://doi.org/10.1124/dmd.108.025056
Johansson, Tove
- You have accessNovel Metabolites of Amodiaquine Formed by CYP1A1 and CYP1B1: Structure Elucidation Using Electrochemistry, Mass Spectrometry, and NMRTove Johansson, Ulrik Jurva, Gunnar Grönberg, Lars Weidolf and Collen MasimirembwaDrug Metabolism and Disposition March 2009, 37 (3) 571-579; DOI: https://doi.org/10.1124/dmd.108.025171
Johnson, Michael G.
- You have accessAn Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple DosingGeorge R. Tonn, Simon G. Wong, Sylvia C. Wong, Michael G. Johnson, Ji Ma, Robert Cho, Leslie C. Floren, Kathryn Kersey, Karen Berry, Andrew P. Marcus, Xuemei Wang, Bettina Van Lengerich, Julio C. Medina, Paul G. Pearson and Bradley K. WongDrug Metabolism and Disposition March 2009, 37 (3) 502-513; DOI: https://doi.org/10.1124/dmd.108.021931
Jørgensen, Flemming Steen
- You have accessClassification of Cytochrome P450 1A2 Inhibitors and Noninhibitors by Machine Learning TechniquesPoongavanam Vasanthanathan, Olivier Taboureau, Chris Oostenbrink, Nico P. E. Vermeulen, Lars Olsen and Flemming Steen JørgensenDrug Metabolism and Disposition March 2009, 37 (3) 658-664; DOI: https://doi.org/10.1124/dmd.108.023507
Jurva, Ulrik
- You have accessNovel Metabolites of Amodiaquine Formed by CYP1A1 and CYP1B1: Structure Elucidation Using Electrochemistry, Mass Spectrometry, and NMRTove Johansson, Ulrik Jurva, Gunnar Grönberg, Lars Weidolf and Collen MasimirembwaDrug Metabolism and Disposition March 2009, 37 (3) 571-579; DOI: https://doi.org/10.1124/dmd.108.025171
K
Kalvass, J. Cory
- You have accessFexofenadine Brain Exposure and the Influence of Blood-Brain Barrier P-Glycoprotein After Fexofenadine and Terfenadine AdministrationRong Zhao, J. Cory Kalvass, Souzan B. Yanni, Arlene S. Bridges and Gary M. PollackDrug Metabolism and Disposition March 2009, 37 (3) 529-535; DOI: https://doi.org/10.1124/dmd.107.019893
Kamataki, Tetsuya
- You have accessSex-Related Differences in the Expression of mfGSTA2, a Novel GST Identified in Cynomolgus Monkey (Macaca fascicularis)Yasuhiro Uno, Tsukasa Ohuchi, Shotaro Uehara, Go Kito, Tetsuya Kamataki and Ryoichi NagataDrug Metabolism and Disposition March 2009, 37 (3) 453-456; DOI: https://doi.org/10.1124/dmd.108.023747
Kamimura, Hidetaka
- You have accessCarrier-Mediated Uptake of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium Bromide (YM155 Monobromide), a Novel Small-Molecule Survivin Suppressant, into Human Solid Tumor and Lymphoma CellsTsuyoshi Minematsu, Megumi Iwai, Kenji Sugimoto, Nobuaki Shirai, Takahito Nakahara, Takashi Usui and Hidetaka KamimuraDrug Metabolism and Disposition March 2009, 37 (3) 619-628; DOI: https://doi.org/10.1124/dmd.108.025254
Kaminsky, Laurence
- You have accessAn Intestinal Epithelium-Specific Cytochrome P450 (P450) Reductase-Knockout Mouse Model: Direct Evidence for a Role of Intestinal P450s in First-Pass Clearance of Oral NifedipineQing-Yu Zhang, Cheng Fang, Jin Zhang, Deborah Dunbar, Laurence Kaminsky and Xinxin DingDrug Metabolism and Disposition March 2009, 37 (3) 651-657; DOI: https://doi.org/10.1124/dmd.108.025429
Kashuba, Angela D. M.
- You have accessIdentification of a Cranberry Juice Product that Inhibits Enteric CYP3A-Mediated First-Pass Metabolism in HumansNgoc Ngo, Zhixia Yan, Tyler N. Graf, Daniel R. Carrizosa, Angela D. M. Kashuba, E. Claire Dees, Nicholas H. Oberlies and Mary F. PaineDrug Metabolism and Disposition March 2009, 37 (3) 514-522; DOI: https://doi.org/10.1124/dmd.108.024968
Kato, Yukio
- You have accessInvestigation of the Role of Oligopeptide Transporter PEPT1 and Sodium/Glucose Cotransporter SGLT1 in Intestinal Absorption of Their Substrates Using Small GTP-Binding Protein Rab8-Null MiceYukio Kato, Tomoko Sugiura, Yasuhito Nakadera, Mikihiro Sugiura, Yoshiyuki Kubo, Takashi Sato, Akihiro Harada and Akira TsujiDrug Metabolism and Disposition March 2009, 37 (3) 602-607; DOI: https://doi.org/10.1124/dmd.108.023689
Kawai, Masahiko
- You have accessDevelopmental Expression and Endocrine Regulation of CYP1B1 in Rat TestisGrace S. Leung, Masahiko Kawai, Jenny K. Tai, Jie Chen, Stelvio M. Bandiera and Thomas K. H. ChangDrug Metabolism and Disposition March 2009, 37 (3) 523-528; DOI: https://doi.org/10.1124/dmd.108.025635
Kersey, Kathryn
- You have accessAn Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple DosingGeorge R. Tonn, Simon G. Wong, Sylvia C. Wong, Michael G. Johnson, Ji Ma, Robert Cho, Leslie C. Floren, Kathryn Kersey, Karen Berry, Andrew P. Marcus, Xuemei Wang, Bettina Van Lengerich, Julio C. Medina, Paul G. Pearson and Bradley K. WongDrug Metabolism and Disposition March 2009, 37 (3) 502-513; DOI: https://doi.org/10.1124/dmd.108.021931
Keshavarzian, Ali
- You have accessSIMDOT-AbMe: Microphysiologically Based Simulation Tool for Quantitative Prediction of Systemic and Local Bioavailability of Targeted Oral Delivery FormulationsNahor Haddish-Berhane, Ashkan Farhadi, Chell Nyquist, Kamyar Haghighi and Ali KeshavarzianDrug Metabolism and Disposition March 2009, 37 (3) 608-618; DOI: https://doi.org/10.1124/dmd.108.021949
Khalizev, Vsevolod A.
- You have access5′-Aminocarbonyl Phosphonates as New Zidovudine Depot Forms: Antiviral Properties, Intracellular Transformations, and Pharmacokinetic ParametersAnastasia L. Khandazhinskaya, Dmitry V. Yanvarev, Maxim V. Jasko, Alexander V. Shipitsin, Vsevolod A. Khalizev, Stanislav I. Shram, Yuriy S. Skoblov, Elena A. Shirokova and Marina K. KukhanovaDrug Metabolism and Disposition March 2009, 37 (3) 494-501; DOI: https://doi.org/10.1124/dmd.108.022269
Khandazhinskaya, Anastasia L.
- You have access5′-Aminocarbonyl Phosphonates as New Zidovudine Depot Forms: Antiviral Properties, Intracellular Transformations, and Pharmacokinetic ParametersAnastasia L. Khandazhinskaya, Dmitry V. Yanvarev, Maxim V. Jasko, Alexander V. Shipitsin, Vsevolod A. Khalizev, Stanislav I. Shram, Yuriy S. Skoblov, Elena A. Shirokova and Marina K. KukhanovaDrug Metabolism and Disposition March 2009, 37 (3) 494-501; DOI: https://doi.org/10.1124/dmd.108.022269
Kito, Go
- You have accessSex-Related Differences in the Expression of mfGSTA2, a Novel GST Identified in Cynomolgus Monkey (Macaca fascicularis)Yasuhiro Uno, Tsukasa Ohuchi, Shotaro Uehara, Go Kito, Tetsuya Kamataki and Ryoichi NagataDrug Metabolism and Disposition March 2009, 37 (3) 453-456; DOI: https://doi.org/10.1124/dmd.108.023747
Knudsen, Gitte M.
- You have accessSpecies Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein TransportStina Syvänen, Örjan Lindhe, Mikael Palner, Birgitte R. Kornum, Obaidur Rahman, Bengt Långström, Gitte M. Knudsen and Margareta Hammarlund-UdenaesDrug Metabolism and Disposition March 2009, 37 (3) 635-643; DOI: https://doi.org/10.1124/dmd.108.024745
Kondo, Tsunenori
- You have accessThe Inhibition of Human Multidrug and Toxin Extrusion 1 Is Involved in the Drug-Drug Interaction Caused by CimetidineSoichiro Matsushima, Kazuya Maeda, Katsuhisa Inoue, Kin-ya Ohta, Hiroaki Yuasa, Tsunenori Kondo, Hideki Nakayama, Shigeru Horita, Hiroyuki Kusuhara and Yuichi SugiyamaDrug Metabolism and Disposition March 2009, 37 (3) 555-559; DOI: https://doi.org/10.1124/dmd.108.023911
Kornum, Birgitte R.
- You have accessSpecies Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein TransportStina Syvänen, Örjan Lindhe, Mikael Palner, Birgitte R. Kornum, Obaidur Rahman, Bengt Långström, Gitte M. Knudsen and Margareta Hammarlund-UdenaesDrug Metabolism and Disposition March 2009, 37 (3) 635-643; DOI: https://doi.org/10.1124/dmd.108.024745
Kramp, Roger
- You have accessDisposition of Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Rats and DogsHandan He, Phi Tran, Hequn Yin, Harold Smith, Dennis Flood, Roger Kramp, Ron Filipeck, Volker Fischer and Dan HowardDrug Metabolism and Disposition March 2009, 37 (3) 545-554; DOI: https://doi.org/10.1124/dmd.108.023002
Kubo, Yoshiyuki
- You have accessInvestigation of the Role of Oligopeptide Transporter PEPT1 and Sodium/Glucose Cotransporter SGLT1 in Intestinal Absorption of Their Substrates Using Small GTP-Binding Protein Rab8-Null MiceYukio Kato, Tomoko Sugiura, Yasuhito Nakadera, Mikihiro Sugiura, Yoshiyuki Kubo, Takashi Sato, Akihiro Harada and Akira TsujiDrug Metabolism and Disposition March 2009, 37 (3) 602-607; DOI: https://doi.org/10.1124/dmd.108.023689
Kukhanova, Marina K.
- You have access5′-Aminocarbonyl Phosphonates as New Zidovudine Depot Forms: Antiviral Properties, Intracellular Transformations, and Pharmacokinetic ParametersAnastasia L. Khandazhinskaya, Dmitry V. Yanvarev, Maxim V. Jasko, Alexander V. Shipitsin, Vsevolod A. Khalizev, Stanislav I. Shram, Yuriy S. Skoblov, Elena A. Shirokova and Marina K. KukhanovaDrug Metabolism and Disposition March 2009, 37 (3) 494-501; DOI: https://doi.org/10.1124/dmd.108.022269
Kumar, Santosh
- You have accessDecreased Susceptibility of the Cytochrome P450 2B6 Variant K262R to Inhibition by Several Clinically Important DrugsJyothi C. Talakad, Santosh Kumar and James R. HalpertDrug Metabolism and Disposition March 2009, 37 (3) 644-650; DOI: https://doi.org/10.1124/dmd.108.023655
- You have accessDehydrogenation of the Indoline-Containing Drug 4-Chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide (Indapamide) by CYP3A4: Correlation with in Silico PredictionsHao Sun, Chad Moore, Patrick M. Dansette, Santosh Kumar, James R. Halpert and Garold S. YostDrug Metabolism and Disposition March 2009, 37 (3) 672-684; DOI: https://doi.org/10.1124/dmd.108.022707
Kurihara, Atsushi
- You have accessMechanism-Based Inhibition of Human Cytochrome P450 2B6 by Ticlopidine, Clopidogrel, and the Thiolactone Metabolite of PrasugrelYumi Nishiya, Katsunobu Hagihara, Takashi Ito, Masami Tajima, Shin-ichi Miura, Atsushi Kurihara, Nagy A. Farid and Toshihiko IkedaDrug Metabolism and Disposition March 2009, 37 (3) 589-593; DOI: https://doi.org/10.1124/dmd.108.022988
Kusuhara, Hiroyuki
- You have accessThe Inhibition of Human Multidrug and Toxin Extrusion 1 Is Involved in the Drug-Drug Interaction Caused by CimetidineSoichiro Matsushima, Kazuya Maeda, Katsuhisa Inoue, Kin-ya Ohta, Hiroaki Yuasa, Tsunenori Kondo, Hideki Nakayama, Shigeru Horita, Hiroyuki Kusuhara and Yuichi SugiyamaDrug Metabolism and Disposition March 2009, 37 (3) 555-559; DOI: https://doi.org/10.1124/dmd.108.023911
L
Lalk, Michael
- You have accessInvestigation of the in Vitro Metabolism of the Analgesic FlupirtineKaren Methling, Przyemslaw Reszka, Michael Lalk, Oldrich Vrana, Eberhard Scheuch, Werner Siegmund, Bernd Terhaag and Patrick J. BednarskiDrug Metabolism and Disposition March 2009, 37 (3) 479-493; DOI: https://doi.org/10.1124/dmd.108.024364
Långström, Bengt
- You have accessSpecies Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein TransportStina Syvänen, Örjan Lindhe, Mikael Palner, Birgitte R. Kornum, Obaidur Rahman, Bengt Långström, Gitte M. Knudsen and Margareta Hammarlund-UdenaesDrug Metabolism and Disposition March 2009, 37 (3) 635-643; DOI: https://doi.org/10.1124/dmd.108.024745
Lecureur, Valérie
- You have accessRegulation of Drug Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokines Tumor Necrosis Factor-α or Interleukin-6Marc Le Vee, Valérie Lecureur, Bruno Stieger and Olivier FardelDrug Metabolism and Disposition March 2009, 37 (3) 685-693; DOI: https://doi.org/10.1124/dmd.108.023630
Lee, David
- You have accessEvaluation of Escherichia coli Membrane Preparations of Canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with Coexpressed Canine Cytochrome P450 ReductaseCharles W. Locuson, Brian T. Ethell, Michael Voice, David Lee and Kenneth L. FeenstraDrug Metabolism and Disposition March 2009, 37 (3) 457-461; DOI: https://doi.org/10.1124/dmd.108.025312
Leung, Grace S.
- You have accessDevelopmental Expression and Endocrine Regulation of CYP1B1 in Rat TestisGrace S. Leung, Masahiko Kawai, Jenny K. Tai, Jie Chen, Stelvio M. Bandiera and Thomas K. H. ChangDrug Metabolism and Disposition March 2009, 37 (3) 523-528; DOI: https://doi.org/10.1124/dmd.108.025635
Li, Ze-Sheng
- You have accessMechanism of CYP2C9 Inhibition by Flavones and FlavonolsDayong Si, Ying Wang, Yi-Han Zhou, Yingjie Guo, Juan Wang, Hui Zhou, Ze-Sheng Li and J. Paul FawcettDrug Metabolism and Disposition March 2009, 37 (3) 629-634; DOI: https://doi.org/10.1124/dmd.108.023416
Lindhe, Örjan
- You have accessSpecies Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein TransportStina Syvänen, Örjan Lindhe, Mikael Palner, Birgitte R. Kornum, Obaidur Rahman, Bengt Långström, Gitte M. Knudsen and Margareta Hammarlund-UdenaesDrug Metabolism and Disposition March 2009, 37 (3) 635-643; DOI: https://doi.org/10.1124/dmd.108.024745
Locuson, Charles W.
- You have accessEvaluation of Escherichia coli Membrane Preparations of Canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with Coexpressed Canine Cytochrome P450 ReductaseCharles W. Locuson, Brian T. Ethell, Michael Voice, David Lee and Kenneth L. FeenstraDrug Metabolism and Disposition March 2009, 37 (3) 457-461; DOI: https://doi.org/10.1124/dmd.108.025312
M
Ma, Ji
- You have accessAn Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple DosingGeorge R. Tonn, Simon G. Wong, Sylvia C. Wong, Michael G. Johnson, Ji Ma, Robert Cho, Leslie C. Floren, Kathryn Kersey, Karen Berry, Andrew P. Marcus, Xuemei Wang, Bettina Van Lengerich, Julio C. Medina, Paul G. Pearson and Bradley K. WongDrug Metabolism and Disposition March 2009, 37 (3) 502-513; DOI: https://doi.org/10.1124/dmd.108.021931
Maeda, Kazuya
- You have accessThe Inhibition of Human Multidrug and Toxin Extrusion 1 Is Involved in the Drug-Drug Interaction Caused by CimetidineSoichiro Matsushima, Kazuya Maeda, Katsuhisa Inoue, Kin-ya Ohta, Hiroaki Yuasa, Tsunenori Kondo, Hideki Nakayama, Shigeru Horita, Hiroyuki Kusuhara and Yuichi SugiyamaDrug Metabolism and Disposition March 2009, 37 (3) 555-559; DOI: https://doi.org/10.1124/dmd.108.023911
Mangold, James B.
- You have accessAbsorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in HumansHandan He, Phi Tran, Hequn Yin, Harold Smith, Yannick Batard, Lai Wang, Heidi Einolf, Helen Gu, James B. Mangold, Volker Fischer and Dan HowardDrug Metabolism and Disposition March 2009, 37 (3) 536-544; DOI: https://doi.org/10.1124/dmd.108.023010
Marcus, Andrew P.
- You have accessAn Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple DosingGeorge R. Tonn, Simon G. Wong, Sylvia C. Wong, Michael G. Johnson, Ji Ma, Robert Cho, Leslie C. Floren, Kathryn Kersey, Karen Berry, Andrew P. Marcus, Xuemei Wang, Bettina Van Lengerich, Julio C. Medina, Paul G. Pearson and Bradley K. WongDrug Metabolism and Disposition March 2009, 37 (3) 502-513; DOI: https://doi.org/10.1124/dmd.108.021931
Masimirembwa, Collen
- You have accessNovel Metabolites of Amodiaquine Formed by CYP1A1 and CYP1B1: Structure Elucidation Using Electrochemistry, Mass Spectrometry, and NMRTove Johansson, Ulrik Jurva, Gunnar Grönberg, Lars Weidolf and Collen MasimirembwaDrug Metabolism and Disposition March 2009, 37 (3) 571-579; DOI: https://doi.org/10.1124/dmd.108.025171
Matsushima, Soichiro
- You have accessThe Inhibition of Human Multidrug and Toxin Extrusion 1 Is Involved in the Drug-Drug Interaction Caused by CimetidineSoichiro Matsushima, Kazuya Maeda, Katsuhisa Inoue, Kin-ya Ohta, Hiroaki Yuasa, Tsunenori Kondo, Hideki Nakayama, Shigeru Horita, Hiroyuki Kusuhara and Yuichi SugiyamaDrug Metabolism and Disposition March 2009, 37 (3) 555-559; DOI: https://doi.org/10.1124/dmd.108.023911
Medina, Julio C.
- You have accessAn Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple DosingGeorge R. Tonn, Simon G. Wong, Sylvia C. Wong, Michael G. Johnson, Ji Ma, Robert Cho, Leslie C. Floren, Kathryn Kersey, Karen Berry, Andrew P. Marcus, Xuemei Wang, Bettina Van Lengerich, Julio C. Medina, Paul G. Pearson and Bradley K. WongDrug Metabolism and Disposition March 2009, 37 (3) 502-513; DOI: https://doi.org/10.1124/dmd.108.021931
Methling, Karen
- You have accessInvestigation of the in Vitro Metabolism of the Analgesic FlupirtineKaren Methling, Przyemslaw Reszka, Michael Lalk, Oldrich Vrana, Eberhard Scheuch, Werner Siegmund, Bernd Terhaag and Patrick J. BednarskiDrug Metabolism and Disposition March 2009, 37 (3) 479-493; DOI: https://doi.org/10.1124/dmd.108.024364
Minematsu, Tsuyoshi
- You have accessCarrier-Mediated Uptake of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium Bromide (YM155 Monobromide), a Novel Small-Molecule Survivin Suppressant, into Human Solid Tumor and Lymphoma CellsTsuyoshi Minematsu, Megumi Iwai, Kenji Sugimoto, Nobuaki Shirai, Takahito Nakahara, Takashi Usui and Hidetaka KamimuraDrug Metabolism and Disposition March 2009, 37 (3) 619-628; DOI: https://doi.org/10.1124/dmd.108.025254
Miura, Shin-ichi
- You have accessMechanism-Based Inhibition of Human Cytochrome P450 2B6 by Ticlopidine, Clopidogrel, and the Thiolactone Metabolite of PrasugrelYumi Nishiya, Katsunobu Hagihara, Takashi Ito, Masami Tajima, Shin-ichi Miura, Atsushi Kurihara, Nagy A. Farid and Toshihiko IkedaDrug Metabolism and Disposition March 2009, 37 (3) 589-593; DOI: https://doi.org/10.1124/dmd.108.022988
Moore, Chad
- You have accessDehydrogenation of the Indoline-Containing Drug 4-Chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide (Indapamide) by CYP3A4: Correlation with in Silico PredictionsHao Sun, Chad Moore, Patrick M. Dansette, Santosh Kumar, James R. Halpert and Garold S. YostDrug Metabolism and Disposition March 2009, 37 (3) 672-684; DOI: https://doi.org/10.1124/dmd.108.022707
Morgan, Edward T.
- You have accessHepatic Flavin-Containing Monooxygenase Gene Regulation in Different Mouse Inflammation ModelsJun Zhang, Madhusudana R. Chaluvadi, Rob Reddy, Meike S. Motika, Terrilyn A. Richardson, John R. Cashman and Edward T. MorganDrug Metabolism and Disposition March 2009, 37 (3) 462-468; DOI: https://doi.org/10.1124/dmd.108.025338
Motika, Meike S.
- You have accessHepatic Flavin-Containing Monooxygenase Gene Regulation in Different Mouse Inflammation ModelsJun Zhang, Madhusudana R. Chaluvadi, Rob Reddy, Meike S. Motika, Terrilyn A. Richardson, John R. Cashman and Edward T. MorganDrug Metabolism and Disposition March 2009, 37 (3) 462-468; DOI: https://doi.org/10.1124/dmd.108.025338
Murphy, Sharon E.
- You have accessEffect of CYP2A13 Active Site Mutation N297A on Metabolism of Coumarin and Tobacco-Specific NitrosaminesKari E. Schlicht, Jeannette Zinggeler Berg and Sharon E. MurphyDrug Metabolism and Disposition March 2009, 37 (3) 665-671; DOI: https://doi.org/10.1124/dmd.108.025072
N
Nagata, Ryoichi
- You have accessSex-Related Differences in the Expression of mfGSTA2, a Novel GST Identified in Cynomolgus Monkey (Macaca fascicularis)Yasuhiro Uno, Tsukasa Ohuchi, Shotaro Uehara, Go Kito, Tetsuya Kamataki and Ryoichi NagataDrug Metabolism and Disposition March 2009, 37 (3) 453-456; DOI: https://doi.org/10.1124/dmd.108.023747
Nakadera, Yasuhito
- You have accessInvestigation of the Role of Oligopeptide Transporter PEPT1 and Sodium/Glucose Cotransporter SGLT1 in Intestinal Absorption of Their Substrates Using Small GTP-Binding Protein Rab8-Null MiceYukio Kato, Tomoko Sugiura, Yasuhito Nakadera, Mikihiro Sugiura, Yoshiyuki Kubo, Takashi Sato, Akihiro Harada and Akira TsujiDrug Metabolism and Disposition March 2009, 37 (3) 602-607; DOI: https://doi.org/10.1124/dmd.108.023689
Nakahara, Takahito
- You have accessCarrier-Mediated Uptake of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium Bromide (YM155 Monobromide), a Novel Small-Molecule Survivin Suppressant, into Human Solid Tumor and Lymphoma CellsTsuyoshi Minematsu, Megumi Iwai, Kenji Sugimoto, Nobuaki Shirai, Takahito Nakahara, Takashi Usui and Hidetaka KamimuraDrug Metabolism and Disposition March 2009, 37 (3) 619-628; DOI: https://doi.org/10.1124/dmd.108.025254
Nakayama, Hideki
- You have accessThe Inhibition of Human Multidrug and Toxin Extrusion 1 Is Involved in the Drug-Drug Interaction Caused by CimetidineSoichiro Matsushima, Kazuya Maeda, Katsuhisa Inoue, Kin-ya Ohta, Hiroaki Yuasa, Tsunenori Kondo, Hideki Nakayama, Shigeru Horita, Hiroyuki Kusuhara and Yuichi SugiyamaDrug Metabolism and Disposition March 2009, 37 (3) 555-559; DOI: https://doi.org/10.1124/dmd.108.023911
Ngo, Ngoc
- You have accessIdentification of a Cranberry Juice Product that Inhibits Enteric CYP3A-Mediated First-Pass Metabolism in HumansNgoc Ngo, Zhixia Yan, Tyler N. Graf, Daniel R. Carrizosa, Angela D. M. Kashuba, E. Claire Dees, Nicholas H. Oberlies and Mary F. PaineDrug Metabolism and Disposition March 2009, 37 (3) 514-522; DOI: https://doi.org/10.1124/dmd.108.024968
Nishiya, Yumi
- You have accessMechanism-Based Inhibition of Human Cytochrome P450 2B6 by Ticlopidine, Clopidogrel, and the Thiolactone Metabolite of PrasugrelYumi Nishiya, Katsunobu Hagihara, Takashi Ito, Masami Tajima, Shin-ichi Miura, Atsushi Kurihara, Nagy A. Farid and Toshihiko IkedaDrug Metabolism and Disposition March 2009, 37 (3) 589-593; DOI: https://doi.org/10.1124/dmd.108.022988
Nyquist, Chell
- You have accessSIMDOT-AbMe: Microphysiologically Based Simulation Tool for Quantitative Prediction of Systemic and Local Bioavailability of Targeted Oral Delivery FormulationsNahor Haddish-Berhane, Ashkan Farhadi, Chell Nyquist, Kamyar Haghighi and Ali KeshavarzianDrug Metabolism and Disposition March 2009, 37 (3) 608-618; DOI: https://doi.org/10.1124/dmd.108.021949
O
Oberlies, Nicholas H.
- You have accessIdentification of a Cranberry Juice Product that Inhibits Enteric CYP3A-Mediated First-Pass Metabolism in HumansNgoc Ngo, Zhixia Yan, Tyler N. Graf, Daniel R. Carrizosa, Angela D. M. Kashuba, E. Claire Dees, Nicholas H. Oberlies and Mary F. PaineDrug Metabolism and Disposition March 2009, 37 (3) 514-522; DOI: https://doi.org/10.1124/dmd.108.024968
Ohta, Kin-ya
- You have accessThe Inhibition of Human Multidrug and Toxin Extrusion 1 Is Involved in the Drug-Drug Interaction Caused by CimetidineSoichiro Matsushima, Kazuya Maeda, Katsuhisa Inoue, Kin-ya Ohta, Hiroaki Yuasa, Tsunenori Kondo, Hideki Nakayama, Shigeru Horita, Hiroyuki Kusuhara and Yuichi SugiyamaDrug Metabolism and Disposition March 2009, 37 (3) 555-559; DOI: https://doi.org/10.1124/dmd.108.023911
Ohuchi, Tsukasa
- You have accessSex-Related Differences in the Expression of mfGSTA2, a Novel GST Identified in Cynomolgus Monkey (Macaca fascicularis)Yasuhiro Uno, Tsukasa Ohuchi, Shotaro Uehara, Go Kito, Tetsuya Kamataki and Ryoichi NagataDrug Metabolism and Disposition March 2009, 37 (3) 453-456; DOI: https://doi.org/10.1124/dmd.108.023747
Olsen, Lars
- You have accessClassification of Cytochrome P450 1A2 Inhibitors and Noninhibitors by Machine Learning TechniquesPoongavanam Vasanthanathan, Olivier Taboureau, Chris Oostenbrink, Nico P. E. Vermeulen, Lars Olsen and Flemming Steen JørgensenDrug Metabolism and Disposition March 2009, 37 (3) 658-664; DOI: https://doi.org/10.1124/dmd.108.023507
Oostenbrink, Chris
- You have accessClassification of Cytochrome P450 1A2 Inhibitors and Noninhibitors by Machine Learning TechniquesPoongavanam Vasanthanathan, Olivier Taboureau, Chris Oostenbrink, Nico P. E. Vermeulen, Lars Olsen and Flemming Steen JørgensenDrug Metabolism and Disposition March 2009, 37 (3) 658-664; DOI: https://doi.org/10.1124/dmd.108.023507
P
Paine, Mary F.
- You have accessIdentification of a Cranberry Juice Product that Inhibits Enteric CYP3A-Mediated First-Pass Metabolism in HumansNgoc Ngo, Zhixia Yan, Tyler N. Graf, Daniel R. Carrizosa, Angela D. M. Kashuba, E. Claire Dees, Nicholas H. Oberlies and Mary F. PaineDrug Metabolism and Disposition March 2009, 37 (3) 514-522; DOI: https://doi.org/10.1124/dmd.108.024968
Palner, Mikael
- You have accessSpecies Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein TransportStina Syvänen, Örjan Lindhe, Mikael Palner, Birgitte R. Kornum, Obaidur Rahman, Bengt Långström, Gitte M. Knudsen and Margareta Hammarlund-UdenaesDrug Metabolism and Disposition March 2009, 37 (3) 635-643; DOI: https://doi.org/10.1124/dmd.108.024745
Pan, Guoyu
- You have accessSubstrate-Dependent Breast Cancer Resistance Protein (Bcrp1/Abcg2)-Mediated Interactions: Consideration of Multiple Binding Sites in in Vitro Assay DesignNagdeep Giri, Sagar Agarwal, Naveed Shaik, Guoyu Pan, Ying Chen and William F. ElmquistDrug Metabolism and Disposition March 2009, 37 (3) 560-570; DOI: https://doi.org/10.1124/dmd.108.022046
Pearson, Paul G.
- You have accessAn Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple DosingGeorge R. Tonn, Simon G. Wong, Sylvia C. Wong, Michael G. Johnson, Ji Ma, Robert Cho, Leslie C. Floren, Kathryn Kersey, Karen Berry, Andrew P. Marcus, Xuemei Wang, Bettina Van Lengerich, Julio C. Medina, Paul G. Pearson and Bradley K. WongDrug Metabolism and Disposition March 2009, 37 (3) 502-513; DOI: https://doi.org/10.1124/dmd.108.021931
Pollack, Gary M.
- You have accessFexofenadine Brain Exposure and the Influence of Blood-Brain Barrier P-Glycoprotein After Fexofenadine and Terfenadine AdministrationRong Zhao, J. Cory Kalvass, Souzan B. Yanni, Arlene S. Bridges and Gary M. PollackDrug Metabolism and Disposition March 2009, 37 (3) 529-535; DOI: https://doi.org/10.1124/dmd.107.019893
R
Rahman, Obaidur
- You have accessSpecies Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein TransportStina Syvänen, Örjan Lindhe, Mikael Palner, Birgitte R. Kornum, Obaidur Rahman, Bengt Långström, Gitte M. Knudsen and Margareta Hammarlund-UdenaesDrug Metabolism and Disposition March 2009, 37 (3) 635-643; DOI: https://doi.org/10.1124/dmd.108.024745
Reddy, Rob
- You have accessHepatic Flavin-Containing Monooxygenase Gene Regulation in Different Mouse Inflammation ModelsJun Zhang, Madhusudana R. Chaluvadi, Rob Reddy, Meike S. Motika, Terrilyn A. Richardson, John R. Cashman and Edward T. MorganDrug Metabolism and Disposition March 2009, 37 (3) 462-468; DOI: https://doi.org/10.1124/dmd.108.025338
Reszka, Przyemslaw
- You have accessInvestigation of the in Vitro Metabolism of the Analgesic FlupirtineKaren Methling, Przyemslaw Reszka, Michael Lalk, Oldrich Vrana, Eberhard Scheuch, Werner Siegmund, Bernd Terhaag and Patrick J. BednarskiDrug Metabolism and Disposition March 2009, 37 (3) 479-493; DOI: https://doi.org/10.1124/dmd.108.024364
Richardson, Terrilyn A.
- You have accessHepatic Flavin-Containing Monooxygenase Gene Regulation in Different Mouse Inflammation ModelsJun Zhang, Madhusudana R. Chaluvadi, Rob Reddy, Meike S. Motika, Terrilyn A. Richardson, John R. Cashman and Edward T. MorganDrug Metabolism and Disposition March 2009, 37 (3) 462-468; DOI: https://doi.org/10.1124/dmd.108.025338
S
Sato, Takashi
- You have accessInvestigation of the Role of Oligopeptide Transporter PEPT1 and Sodium/Glucose Cotransporter SGLT1 in Intestinal Absorption of Their Substrates Using Small GTP-Binding Protein Rab8-Null MiceYukio Kato, Tomoko Sugiura, Yasuhito Nakadera, Mikihiro Sugiura, Yoshiyuki Kubo, Takashi Sato, Akihiro Harada and Akira TsujiDrug Metabolism and Disposition March 2009, 37 (3) 602-607; DOI: https://doi.org/10.1124/dmd.108.023689
Scheuch, Eberhard
- You have accessInvestigation of the in Vitro Metabolism of the Analgesic FlupirtineKaren Methling, Przyemslaw Reszka, Michael Lalk, Oldrich Vrana, Eberhard Scheuch, Werner Siegmund, Bernd Terhaag and Patrick J. BednarskiDrug Metabolism and Disposition March 2009, 37 (3) 479-493; DOI: https://doi.org/10.1124/dmd.108.024364
Schlicht, Kari E.
- You have accessEffect of CYP2A13 Active Site Mutation N297A on Metabolism of Coumarin and Tobacco-Specific NitrosaminesKari E. Schlicht, Jeannette Zinggeler Berg and Sharon E. MurphyDrug Metabolism and Disposition March 2009, 37 (3) 665-671; DOI: https://doi.org/10.1124/dmd.108.025072
Shaik, Naveed
- You have accessSubstrate-Dependent Breast Cancer Resistance Protein (Bcrp1/Abcg2)-Mediated Interactions: Consideration of Multiple Binding Sites in in Vitro Assay DesignNagdeep Giri, Sagar Agarwal, Naveed Shaik, Guoyu Pan, Ying Chen and William F. ElmquistDrug Metabolism and Disposition March 2009, 37 (3) 560-570; DOI: https://doi.org/10.1124/dmd.108.022046
Shen, Hong-Wu
- You have accessPinoline May be Used as a Probe for CYP2D6 ActivityXi-Ling Jiang, Hong-Wu Shen and Ai-Ming YuDrug Metabolism and Disposition March 2009, 37 (3) 443-446; DOI: https://doi.org/10.1124/dmd.108.025056
Shipitsin, Alexander V.
- You have access5′-Aminocarbonyl Phosphonates as New Zidovudine Depot Forms: Antiviral Properties, Intracellular Transformations, and Pharmacokinetic ParametersAnastasia L. Khandazhinskaya, Dmitry V. Yanvarev, Maxim V. Jasko, Alexander V. Shipitsin, Vsevolod A. Khalizev, Stanislav I. Shram, Yuriy S. Skoblov, Elena A. Shirokova and Marina K. KukhanovaDrug Metabolism and Disposition March 2009, 37 (3) 494-501; DOI: https://doi.org/10.1124/dmd.108.022269
Shirai, Nobuaki
- You have accessCarrier-Mediated Uptake of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium Bromide (YM155 Monobromide), a Novel Small-Molecule Survivin Suppressant, into Human Solid Tumor and Lymphoma CellsTsuyoshi Minematsu, Megumi Iwai, Kenji Sugimoto, Nobuaki Shirai, Takahito Nakahara, Takashi Usui and Hidetaka KamimuraDrug Metabolism and Disposition March 2009, 37 (3) 619-628; DOI: https://doi.org/10.1124/dmd.108.025254
Shirokova, Elena A.
- You have access5′-Aminocarbonyl Phosphonates as New Zidovudine Depot Forms: Antiviral Properties, Intracellular Transformations, and Pharmacokinetic ParametersAnastasia L. Khandazhinskaya, Dmitry V. Yanvarev, Maxim V. Jasko, Alexander V. Shipitsin, Vsevolod A. Khalizev, Stanislav I. Shram, Yuriy S. Skoblov, Elena A. Shirokova and Marina K. KukhanovaDrug Metabolism and Disposition March 2009, 37 (3) 494-501; DOI: https://doi.org/10.1124/dmd.108.022269
Shram, Stanislav I.
- You have access5′-Aminocarbonyl Phosphonates as New Zidovudine Depot Forms: Antiviral Properties, Intracellular Transformations, and Pharmacokinetic ParametersAnastasia L. Khandazhinskaya, Dmitry V. Yanvarev, Maxim V. Jasko, Alexander V. Shipitsin, Vsevolod A. Khalizev, Stanislav I. Shram, Yuriy S. Skoblov, Elena A. Shirokova and Marina K. KukhanovaDrug Metabolism and Disposition March 2009, 37 (3) 494-501; DOI: https://doi.org/10.1124/dmd.108.022269
Si, Dayong
- You have accessMechanism of CYP2C9 Inhibition by Flavones and FlavonolsDayong Si, Ying Wang, Yi-Han Zhou, Yingjie Guo, Juan Wang, Hui Zhou, Ze-Sheng Li and J. Paul FawcettDrug Metabolism and Disposition March 2009, 37 (3) 629-634; DOI: https://doi.org/10.1124/dmd.108.023416
Siegmund, Werner
- You have accessInvestigation of the in Vitro Metabolism of the Analgesic FlupirtineKaren Methling, Przyemslaw Reszka, Michael Lalk, Oldrich Vrana, Eberhard Scheuch, Werner Siegmund, Bernd Terhaag and Patrick J. BednarskiDrug Metabolism and Disposition March 2009, 37 (3) 479-493; DOI: https://doi.org/10.1124/dmd.108.024364
Silverman, Jeffrey A.
- You have accessMetabolism of (+)-1,4-Dihydro-7-(trans-3-methoxy-4-methylamino-1-pyrrolidinyl)-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic Acid (Voreloxin; Formerly SNS-595), a Novel Replication-Dependent DNA-Damaging AgentMarc J. Evanchik, Darin Allen, Josh C. Yoburn, Jeffrey A. Silverman and Ute HochDrug Metabolism and Disposition March 2009, 37 (3) 594-601; DOI: https://doi.org/10.1124/dmd.108.023432
Skoblov, Yuriy S.
- You have access5′-Aminocarbonyl Phosphonates as New Zidovudine Depot Forms: Antiviral Properties, Intracellular Transformations, and Pharmacokinetic ParametersAnastasia L. Khandazhinskaya, Dmitry V. Yanvarev, Maxim V. Jasko, Alexander V. Shipitsin, Vsevolod A. Khalizev, Stanislav I. Shram, Yuriy S. Skoblov, Elena A. Shirokova and Marina K. KukhanovaDrug Metabolism and Disposition March 2009, 37 (3) 494-501; DOI: https://doi.org/10.1124/dmd.108.022269
Smith, Harold
- You have accessAbsorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in HumansHandan He, Phi Tran, Hequn Yin, Harold Smith, Yannick Batard, Lai Wang, Heidi Einolf, Helen Gu, James B. Mangold, Volker Fischer and Dan HowardDrug Metabolism and Disposition March 2009, 37 (3) 536-544; DOI: https://doi.org/10.1124/dmd.108.023010
- You have accessDisposition of Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Rats and DogsHandan He, Phi Tran, Hequn Yin, Harold Smith, Dennis Flood, Roger Kramp, Ron Filipeck, Volker Fischer and Dan HowardDrug Metabolism and Disposition March 2009, 37 (3) 545-554; DOI: https://doi.org/10.1124/dmd.108.023002
Stieger, Bruno
- You have accessRegulation of Drug Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokines Tumor Necrosis Factor-α or Interleukin-6Marc Le Vee, Valérie Lecureur, Bruno Stieger and Olivier FardelDrug Metabolism and Disposition March 2009, 37 (3) 685-693; DOI: https://doi.org/10.1124/dmd.108.023630
Sugimoto, Kenji
- You have accessCarrier-Mediated Uptake of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium Bromide (YM155 Monobromide), a Novel Small-Molecule Survivin Suppressant, into Human Solid Tumor and Lymphoma CellsTsuyoshi Minematsu, Megumi Iwai, Kenji Sugimoto, Nobuaki Shirai, Takahito Nakahara, Takashi Usui and Hidetaka KamimuraDrug Metabolism and Disposition March 2009, 37 (3) 619-628; DOI: https://doi.org/10.1124/dmd.108.025254
Sugiura, Mikihiro
- You have accessInvestigation of the Role of Oligopeptide Transporter PEPT1 and Sodium/Glucose Cotransporter SGLT1 in Intestinal Absorption of Their Substrates Using Small GTP-Binding Protein Rab8-Null MiceYukio Kato, Tomoko Sugiura, Yasuhito Nakadera, Mikihiro Sugiura, Yoshiyuki Kubo, Takashi Sato, Akihiro Harada and Akira TsujiDrug Metabolism and Disposition March 2009, 37 (3) 602-607; DOI: https://doi.org/10.1124/dmd.108.023689
Sugiura, Tomoko
- You have accessInvestigation of the Role of Oligopeptide Transporter PEPT1 and Sodium/Glucose Cotransporter SGLT1 in Intestinal Absorption of Their Substrates Using Small GTP-Binding Protein Rab8-Null MiceYukio Kato, Tomoko Sugiura, Yasuhito Nakadera, Mikihiro Sugiura, Yoshiyuki Kubo, Takashi Sato, Akihiro Harada and Akira TsujiDrug Metabolism and Disposition March 2009, 37 (3) 602-607; DOI: https://doi.org/10.1124/dmd.108.023689
Sugiyama, Yuichi
- You have accessThe Inhibition of Human Multidrug and Toxin Extrusion 1 Is Involved in the Drug-Drug Interaction Caused by CimetidineSoichiro Matsushima, Kazuya Maeda, Katsuhisa Inoue, Kin-ya Ohta, Hiroaki Yuasa, Tsunenori Kondo, Hideki Nakayama, Shigeru Horita, Hiroyuki Kusuhara and Yuichi SugiyamaDrug Metabolism and Disposition March 2009, 37 (3) 555-559; DOI: https://doi.org/10.1124/dmd.108.023911
Sun, Hao
- You have accessDehydrogenation of the Indoline-Containing Drug 4-Chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide (Indapamide) by CYP3A4: Correlation with in Silico PredictionsHao Sun, Chad Moore, Patrick M. Dansette, Santosh Kumar, James R. Halpert and Garold S. YostDrug Metabolism and Disposition March 2009, 37 (3) 672-684; DOI: https://doi.org/10.1124/dmd.108.022707
Syvänen, Stina
- You have accessSpecies Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein TransportStina Syvänen, Örjan Lindhe, Mikael Palner, Birgitte R. Kornum, Obaidur Rahman, Bengt Långström, Gitte M. Knudsen and Margareta Hammarlund-UdenaesDrug Metabolism and Disposition March 2009, 37 (3) 635-643; DOI: https://doi.org/10.1124/dmd.108.024745
T
Taboureau, Olivier
- You have accessClassification of Cytochrome P450 1A2 Inhibitors and Noninhibitors by Machine Learning TechniquesPoongavanam Vasanthanathan, Olivier Taboureau, Chris Oostenbrink, Nico P. E. Vermeulen, Lars Olsen and Flemming Steen JørgensenDrug Metabolism and Disposition March 2009, 37 (3) 658-664; DOI: https://doi.org/10.1124/dmd.108.023507
Tai, Jenny K.
- You have accessDevelopmental Expression and Endocrine Regulation of CYP1B1 in Rat TestisGrace S. Leung, Masahiko Kawai, Jenny K. Tai, Jie Chen, Stelvio M. Bandiera and Thomas K. H. ChangDrug Metabolism and Disposition March 2009, 37 (3) 523-528; DOI: https://doi.org/10.1124/dmd.108.025635
Tajima, Masami
- You have accessMechanism-Based Inhibition of Human Cytochrome P450 2B6 by Ticlopidine, Clopidogrel, and the Thiolactone Metabolite of PrasugrelYumi Nishiya, Katsunobu Hagihara, Takashi Ito, Masami Tajima, Shin-ichi Miura, Atsushi Kurihara, Nagy A. Farid and Toshihiko IkedaDrug Metabolism and Disposition March 2009, 37 (3) 589-593; DOI: https://doi.org/10.1124/dmd.108.022988
Talakad, Jyothi C.
- You have accessDecreased Susceptibility of the Cytochrome P450 2B6 Variant K262R to Inhibition by Several Clinically Important DrugsJyothi C. Talakad, Santosh Kumar and James R. HalpertDrug Metabolism and Disposition March 2009, 37 (3) 644-650; DOI: https://doi.org/10.1124/dmd.108.023655
Terhaag, Bernd
- You have accessInvestigation of the in Vitro Metabolism of the Analgesic FlupirtineKaren Methling, Przyemslaw Reszka, Michael Lalk, Oldrich Vrana, Eberhard Scheuch, Werner Siegmund, Bernd Terhaag and Patrick J. BednarskiDrug Metabolism and Disposition March 2009, 37 (3) 479-493; DOI: https://doi.org/10.1124/dmd.108.024364
Tonn, George R.
- You have accessAn Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple DosingGeorge R. Tonn, Simon G. Wong, Sylvia C. Wong, Michael G. Johnson, Ji Ma, Robert Cho, Leslie C. Floren, Kathryn Kersey, Karen Berry, Andrew P. Marcus, Xuemei Wang, Bettina Van Lengerich, Julio C. Medina, Paul G. Pearson and Bradley K. WongDrug Metabolism and Disposition March 2009, 37 (3) 502-513; DOI: https://doi.org/10.1124/dmd.108.021931
Tran, Phi
- You have accessAbsorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in HumansHandan He, Phi Tran, Hequn Yin, Harold Smith, Yannick Batard, Lai Wang, Heidi Einolf, Helen Gu, James B. Mangold, Volker Fischer and Dan HowardDrug Metabolism and Disposition March 2009, 37 (3) 536-544; DOI: https://doi.org/10.1124/dmd.108.023010
- You have accessDisposition of Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Rats and DogsHandan He, Phi Tran, Hequn Yin, Harold Smith, Dennis Flood, Roger Kramp, Ron Filipeck, Volker Fischer and Dan HowardDrug Metabolism and Disposition March 2009, 37 (3) 545-554; DOI: https://doi.org/10.1124/dmd.108.023002
Tsuji, Akira
- You have accessInvestigation of the Role of Oligopeptide Transporter PEPT1 and Sodium/Glucose Cotransporter SGLT1 in Intestinal Absorption of Their Substrates Using Small GTP-Binding Protein Rab8-Null MiceYukio Kato, Tomoko Sugiura, Yasuhito Nakadera, Mikihiro Sugiura, Yoshiyuki Kubo, Takashi Sato, Akihiro Harada and Akira TsujiDrug Metabolism and Disposition March 2009, 37 (3) 602-607; DOI: https://doi.org/10.1124/dmd.108.023689
U
Uehara, Shotaro
- You have accessSex-Related Differences in the Expression of mfGSTA2, a Novel GST Identified in Cynomolgus Monkey (Macaca fascicularis)Yasuhiro Uno, Tsukasa Ohuchi, Shotaro Uehara, Go Kito, Tetsuya Kamataki and Ryoichi NagataDrug Metabolism and Disposition March 2009, 37 (3) 453-456; DOI: https://doi.org/10.1124/dmd.108.023747
Uno, Yasuhiro
- You have accessSex-Related Differences in the Expression of mfGSTA2, a Novel GST Identified in Cynomolgus Monkey (Macaca fascicularis)Yasuhiro Uno, Tsukasa Ohuchi, Shotaro Uehara, Go Kito, Tetsuya Kamataki and Ryoichi NagataDrug Metabolism and Disposition March 2009, 37 (3) 453-456; DOI: https://doi.org/10.1124/dmd.108.023747
Usui, Takashi
- You have accessCarrier-Mediated Uptake of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium Bromide (YM155 Monobromide), a Novel Small-Molecule Survivin Suppressant, into Human Solid Tumor and Lymphoma CellsTsuyoshi Minematsu, Megumi Iwai, Kenji Sugimoto, Nobuaki Shirai, Takahito Nakahara, Takashi Usui and Hidetaka KamimuraDrug Metabolism and Disposition March 2009, 37 (3) 619-628; DOI: https://doi.org/10.1124/dmd.108.025254
V
Van Lengerich, Bettina
- You have accessAn Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple DosingGeorge R. Tonn, Simon G. Wong, Sylvia C. Wong, Michael G. Johnson, Ji Ma, Robert Cho, Leslie C. Floren, Kathryn Kersey, Karen Berry, Andrew P. Marcus, Xuemei Wang, Bettina Van Lengerich, Julio C. Medina, Paul G. Pearson and Bradley K. WongDrug Metabolism and Disposition March 2009, 37 (3) 502-513; DOI: https://doi.org/10.1124/dmd.108.021931
Vasanthanathan, Poongavanam
- You have accessClassification of Cytochrome P450 1A2 Inhibitors and Noninhibitors by Machine Learning TechniquesPoongavanam Vasanthanathan, Olivier Taboureau, Chris Oostenbrink, Nico P. E. Vermeulen, Lars Olsen and Flemming Steen JørgensenDrug Metabolism and Disposition March 2009, 37 (3) 658-664; DOI: https://doi.org/10.1124/dmd.108.023507
Vee, Marc Le
- You have accessRegulation of Drug Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokines Tumor Necrosis Factor-α or Interleukin-6Marc Le Vee, Valérie Lecureur, Bruno Stieger and Olivier FardelDrug Metabolism and Disposition March 2009, 37 (3) 685-693; DOI: https://doi.org/10.1124/dmd.108.023630
Vermeulen, Nico P. E.
- You have accessClassification of Cytochrome P450 1A2 Inhibitors and Noninhibitors by Machine Learning TechniquesPoongavanam Vasanthanathan, Olivier Taboureau, Chris Oostenbrink, Nico P. E. Vermeulen, Lars Olsen and Flemming Steen JørgensenDrug Metabolism and Disposition March 2009, 37 (3) 658-664; DOI: https://doi.org/10.1124/dmd.108.023507
Voice, Michael
- You have accessEvaluation of Escherichia coli Membrane Preparations of Canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with Coexpressed Canine Cytochrome P450 ReductaseCharles W. Locuson, Brian T. Ethell, Michael Voice, David Lee and Kenneth L. FeenstraDrug Metabolism and Disposition March 2009, 37 (3) 457-461; DOI: https://doi.org/10.1124/dmd.108.025312
Vrana, Oldrich
- You have accessInvestigation of the in Vitro Metabolism of the Analgesic FlupirtineKaren Methling, Przyemslaw Reszka, Michael Lalk, Oldrich Vrana, Eberhard Scheuch, Werner Siegmund, Bernd Terhaag and Patrick J. BednarskiDrug Metabolism and Disposition March 2009, 37 (3) 479-493; DOI: https://doi.org/10.1124/dmd.108.024364
W
Wang, Juan
- You have accessMechanism of CYP2C9 Inhibition by Flavones and FlavonolsDayong Si, Ying Wang, Yi-Han Zhou, Yingjie Guo, Juan Wang, Hui Zhou, Ze-Sheng Li and J. Paul FawcettDrug Metabolism and Disposition March 2009, 37 (3) 629-634; DOI: https://doi.org/10.1124/dmd.108.023416
Wang, Lai
- You have accessAbsorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in HumansHandan He, Phi Tran, Hequn Yin, Harold Smith, Yannick Batard, Lai Wang, Heidi Einolf, Helen Gu, James B. Mangold, Volker Fischer and Dan HowardDrug Metabolism and Disposition March 2009, 37 (3) 536-544; DOI: https://doi.org/10.1124/dmd.108.023010
Wang, Xuemei
- You have accessAn Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple DosingGeorge R. Tonn, Simon G. Wong, Sylvia C. Wong, Michael G. Johnson, Ji Ma, Robert Cho, Leslie C. Floren, Kathryn Kersey, Karen Berry, Andrew P. Marcus, Xuemei Wang, Bettina Van Lengerich, Julio C. Medina, Paul G. Pearson and Bradley K. WongDrug Metabolism and Disposition March 2009, 37 (3) 502-513; DOI: https://doi.org/10.1124/dmd.108.021931
Wang, Ying
- You have accessMechanism of CYP2C9 Inhibition by Flavones and FlavonolsDayong Si, Ying Wang, Yi-Han Zhou, Yingjie Guo, Juan Wang, Hui Zhou, Ze-Sheng Li and J. Paul FawcettDrug Metabolism and Disposition March 2009, 37 (3) 629-634; DOI: https://doi.org/10.1124/dmd.108.023416
Weidolf, Lars
- You have accessNovel Metabolites of Amodiaquine Formed by CYP1A1 and CYP1B1: Structure Elucidation Using Electrochemistry, Mass Spectrometry, and NMRTove Johansson, Ulrik Jurva, Gunnar Grönberg, Lars Weidolf and Collen MasimirembwaDrug Metabolism and Disposition March 2009, 37 (3) 571-579; DOI: https://doi.org/10.1124/dmd.108.025171
Wong, Bradley K.
- You have accessAn Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple DosingGeorge R. Tonn, Simon G. Wong, Sylvia C. Wong, Michael G. Johnson, Ji Ma, Robert Cho, Leslie C. Floren, Kathryn Kersey, Karen Berry, Andrew P. Marcus, Xuemei Wang, Bettina Van Lengerich, Julio C. Medina, Paul G. Pearson and Bradley K. WongDrug Metabolism and Disposition March 2009, 37 (3) 502-513; DOI: https://doi.org/10.1124/dmd.108.021931
Wong, Simon G.
- You have accessAn Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple DosingGeorge R. Tonn, Simon G. Wong, Sylvia C. Wong, Michael G. Johnson, Ji Ma, Robert Cho, Leslie C. Floren, Kathryn Kersey, Karen Berry, Andrew P. Marcus, Xuemei Wang, Bettina Van Lengerich, Julio C. Medina, Paul G. Pearson and Bradley K. WongDrug Metabolism and Disposition March 2009, 37 (3) 502-513; DOI: https://doi.org/10.1124/dmd.108.021931
Wong, Sylvia C.
- You have accessAn Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple DosingGeorge R. Tonn, Simon G. Wong, Sylvia C. Wong, Michael G. Johnson, Ji Ma, Robert Cho, Leslie C. Floren, Kathryn Kersey, Karen Berry, Andrew P. Marcus, Xuemei Wang, Bettina Van Lengerich, Julio C. Medina, Paul G. Pearson and Bradley K. WongDrug Metabolism and Disposition March 2009, 37 (3) 502-513; DOI: https://doi.org/10.1124/dmd.108.021931
Y
Yan, Zhixia
- You have accessIdentification of a Cranberry Juice Product that Inhibits Enteric CYP3A-Mediated First-Pass Metabolism in HumansNgoc Ngo, Zhixia Yan, Tyler N. Graf, Daniel R. Carrizosa, Angela D. M. Kashuba, E. Claire Dees, Nicholas H. Oberlies and Mary F. PaineDrug Metabolism and Disposition March 2009, 37 (3) 514-522; DOI: https://doi.org/10.1124/dmd.108.024968
Yanni, Souzan B.
- You have accessFexofenadine Brain Exposure and the Influence of Blood-Brain Barrier P-Glycoprotein After Fexofenadine and Terfenadine AdministrationRong Zhao, J. Cory Kalvass, Souzan B. Yanni, Arlene S. Bridges and Gary M. PollackDrug Metabolism and Disposition March 2009, 37 (3) 529-535; DOI: https://doi.org/10.1124/dmd.107.019893
Yanvarev, Dmitry V.
- You have access5′-Aminocarbonyl Phosphonates as New Zidovudine Depot Forms: Antiviral Properties, Intracellular Transformations, and Pharmacokinetic ParametersAnastasia L. Khandazhinskaya, Dmitry V. Yanvarev, Maxim V. Jasko, Alexander V. Shipitsin, Vsevolod A. Khalizev, Stanislav I. Shram, Yuriy S. Skoblov, Elena A. Shirokova and Marina K. KukhanovaDrug Metabolism and Disposition March 2009, 37 (3) 494-501; DOI: https://doi.org/10.1124/dmd.108.022269
Yin, Hequn
- You have accessAbsorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in HumansHandan He, Phi Tran, Hequn Yin, Harold Smith, Yannick Batard, Lai Wang, Heidi Einolf, Helen Gu, James B. Mangold, Volker Fischer and Dan HowardDrug Metabolism and Disposition March 2009, 37 (3) 536-544; DOI: https://doi.org/10.1124/dmd.108.023010
- You have accessDisposition of Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Rats and DogsHandan He, Phi Tran, Hequn Yin, Harold Smith, Dennis Flood, Roger Kramp, Ron Filipeck, Volker Fischer and Dan HowardDrug Metabolism and Disposition March 2009, 37 (3) 545-554; DOI: https://doi.org/10.1124/dmd.108.023002
Yoburn, Josh C.
- You have accessMetabolism of (+)-1,4-Dihydro-7-(trans-3-methoxy-4-methylamino-1-pyrrolidinyl)-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic Acid (Voreloxin; Formerly SNS-595), a Novel Replication-Dependent DNA-Damaging AgentMarc J. Evanchik, Darin Allen, Josh C. Yoburn, Jeffrey A. Silverman and Ute HochDrug Metabolism and Disposition March 2009, 37 (3) 594-601; DOI: https://doi.org/10.1124/dmd.108.023432
Yost, Garold S.
- You have accessDehydrogenation of the Indoline-Containing Drug 4-Chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide (Indapamide) by CYP3A4: Correlation with in Silico PredictionsHao Sun, Chad Moore, Patrick M. Dansette, Santosh Kumar, James R. Halpert and Garold S. YostDrug Metabolism and Disposition March 2009, 37 (3) 672-684; DOI: https://doi.org/10.1124/dmd.108.022707
Yu, Ai-Ming
- You have accessPinoline May be Used as a Probe for CYP2D6 ActivityXi-Ling Jiang, Hong-Wu Shen and Ai-Ming YuDrug Metabolism and Disposition March 2009, 37 (3) 443-446; DOI: https://doi.org/10.1124/dmd.108.025056
Yuasa, Hiroaki
- You have accessThe Inhibition of Human Multidrug and Toxin Extrusion 1 Is Involved in the Drug-Drug Interaction Caused by CimetidineSoichiro Matsushima, Kazuya Maeda, Katsuhisa Inoue, Kin-ya Ohta, Hiroaki Yuasa, Tsunenori Kondo, Hideki Nakayama, Shigeru Horita, Hiroyuki Kusuhara and Yuichi SugiyamaDrug Metabolism and Disposition March 2009, 37 (3) 555-559; DOI: https://doi.org/10.1124/dmd.108.023911
Z
Zhang, Jin
- You have accessAn Intestinal Epithelium-Specific Cytochrome P450 (P450) Reductase-Knockout Mouse Model: Direct Evidence for a Role of Intestinal P450s in First-Pass Clearance of Oral NifedipineQing-Yu Zhang, Cheng Fang, Jin Zhang, Deborah Dunbar, Laurence Kaminsky and Xinxin DingDrug Metabolism and Disposition March 2009, 37 (3) 651-657; DOI: https://doi.org/10.1124/dmd.108.025429
Zhang, Jun
- You have accessHepatic Flavin-Containing Monooxygenase Gene Regulation in Different Mouse Inflammation ModelsJun Zhang, Madhusudana R. Chaluvadi, Rob Reddy, Meike S. Motika, Terrilyn A. Richardson, John R. Cashman and Edward T. MorganDrug Metabolism and Disposition March 2009, 37 (3) 462-468; DOI: https://doi.org/10.1124/dmd.108.025338
Zhang, Qing-Yu
- You have accessAn Intestinal Epithelium-Specific Cytochrome P450 (P450) Reductase-Knockout Mouse Model: Direct Evidence for a Role of Intestinal P450s in First-Pass Clearance of Oral NifedipineQing-Yu Zhang, Cheng Fang, Jin Zhang, Deborah Dunbar, Laurence Kaminsky and Xinxin DingDrug Metabolism and Disposition March 2009, 37 (3) 651-657; DOI: https://doi.org/10.1124/dmd.108.025429
Zhao, Rong
- You have accessFexofenadine Brain Exposure and the Influence of Blood-Brain Barrier P-Glycoprotein After Fexofenadine and Terfenadine AdministrationRong Zhao, J. Cory Kalvass, Souzan B. Yanni, Arlene S. Bridges and Gary M. PollackDrug Metabolism and Disposition March 2009, 37 (3) 529-535; DOI: https://doi.org/10.1124/dmd.107.019893
Zhou, Hui
- You have accessMechanism of CYP2C9 Inhibition by Flavones and FlavonolsDayong Si, Ying Wang, Yi-Han Zhou, Yingjie Guo, Juan Wang, Hui Zhou, Ze-Sheng Li and J. Paul FawcettDrug Metabolism and Disposition March 2009, 37 (3) 629-634; DOI: https://doi.org/10.1124/dmd.108.023416
Zhou, Yi-Han
- You have accessMechanism of CYP2C9 Inhibition by Flavones and FlavonolsDayong Si, Ying Wang, Yi-Han Zhou, Yingjie Guo, Juan Wang, Hui Zhou, Ze-Sheng Li and J. Paul FawcettDrug Metabolism and Disposition March 2009, 37 (3) 629-634; DOI: https://doi.org/10.1124/dmd.108.023416
In this issue

Advertisement